Advice
in the absence of a submission from the holder of the marketing authorisation:
estetrol / drospirenone (Drovelis®) is not recommended for use within NHSScotland.
Indication under review: Oral contraception.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice623KB (PDF)
Medicine details
- Medicine name:
- estetrol / drospirenone (Drovelis)
- SMC ID:
- SMC2564
- Indication:
Oral contraception
- Pharmaceutical company
- Gedeon Richter UK Ltd
- BNF chapter
- Obstetrics, gynaecology, and urinary-tract disorders
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 16 January 2023